newsfilter
← Latest News
GlobeNewswire·

180 Life Sciences Issues Letter to Stockholders

PALO ALTO, Calif., Sept. 26, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), a clinical-stage biotechnology company today released the following letter to stockholders from its Chief Executive Offi